PANCREATIC CANCER THERAPEUTICS AND DIAGNOSTIC MARKET ANALYSIS

Pancreatic Cancer Therapeutics and Diagnostic Market, By Type (Treatment (Targeted Therapies, Chemotherapy, Surgery, and Other Treatments) and Diagnostics (Imaging, Biopsy, Endoscopic Ultrasound, and Other Diagnostics), and Geography (North America, Europe, Asia Pacific, Middle East, Africa, and Latin America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Published In : Jan 2023
Code : CMI5473
Pages :170
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Global Pancreatic Cancer Therapeutics and Diagnostic Market: Key Companies Insights

The pancreatic cancer therapeutics and diagnostic market is highly competitive. This is attributed to the increase in demand for safe and effective therapeutics, as a result, players in the market are focusing on launching novel products in the market.

Some of the key players in the global pancreatic cancer therapeutics and diagnostic market are F Hoffmann-La Roche AG, Merck KgaA, Apexigen Inc., Immunovia AB, Viatris Inc., Amgen Inc., AstraZeneca PLC, Bristol-Myers Squibb, Novartis AG, Pfizer Inc., Myriad Genetics Inc., Canon Medical Systems Corporation, FUJIFILM Holdings Corporation, Boston Scientific Corporation, and Rafael Holdings Inc. (Rafael Pharmaceuticals), among others.